Figure 3. FLE treatment combined with low-dose tetracycline
A) A 19 year old male patient presenting with baseline acne
severity of IGA 3. The patient was previously treated with topical
treatment and tetracycline without effect. Wishing fast response and
unable to meet frequent blood analysis required for standard dose of
isotretinoin therapy. The patient was started in low-dose isotretinoin
combined with FLE treatment. B) A 19 year old male patient
presenting with baseline acne severity of IGA 3, previously undergoing
topical and tetracycline therapy without effect and discontinued
isotretinoin treatment due to adverse effects. The patient was started
on tetracycline combined with FLE treatment. C) A 17 year old
male patient presenting with baseline acne severity of IGA 3. The
patient was previously treated with topical treatment without effect.
Now wishing a fast response, the patient was started on tetracycline
combined with FLE treatment. D) A 24 year old female patient
presenting with baseline acne severity of IGA 3. The patient was
previously treated with topical treatment, tetracycline with
norelgestromin/ethinylestradiol (Evra), without effect. The patient was
started on tetracycline and norelgestromin/ethinyl estradiol (BCP)
combined with FLE treatment. Appearance of the skin as presented at each
evaluation; baseline (upper row), week 6 (second row from top), week 12
(third row from top), week 33 (fourth row from top), and week 52 (bottom
row).